BACKGROUND: Hydrocortisone therapy is based on a dosing regimen derived from estimates of cortisol secretion, but little is known of how the dose should be distributed throughout the 24 h. We have used deconvolution analysis of 24-h serum cortisol profiles to determine 24-h cortisol secretion and distribution to inform hydrocortisone dosing schedules in young children and older adults. METHODS: Twenty four hour serum cortisol profiles from 80 adults (41 men, aged 60-74 years) and 29 children (24 boys, aged 5-9 years) were subject to deconvolution analysis using an 80-min half-life to ascertain total cortisol secretion and distribution throughout the 24-h period. RESULTS: Mean daily cortisol secretion was similar between adults (6.3 mg/m(2) ...
Objective: Treatment of classic congenital adrenal hyperplasia (CAH) is necessary to compensate for ...
The aim of glucocorticoid replacement therapy in ACTH-deficient patients is to mimic the normal diur...
Context Hydrocortisone treatment of young patients with 21-hydroxylase deficiency (21OHD) is given t...
Objective: Oral once-daily dual-release hydrocortisone (DR-HC) replacement therapy was developed to ...
Objective: Oral once-daily dual-release hydrocortisone (DR-HC) replacement therapy was developed to ...
Background and objective: Optimisation of hydrocortisone replacement therapy in children is challeng...
International audienceBackgroundAdjustment of daily hydrocortisone dose on clinical criteria lacks s...
International audienceBackgroundAdjustment of daily hydrocortisone dose on clinical criteria lacks s...
International audienceBackgroundAdjustment of daily hydrocortisone dose on clinical criteria lacks s...
International audienceBackgroundAdjustment of daily hydrocortisone dose on clinical criteria lacks s...
There is an increase in mortality and morbidity as well as poor quality of life in patients with con...
<div><p>Background</p><p>Adjustment of daily hydrocortisone dose on clinical criteria lacks sensitiv...
Background: Glucocorticoid replacement is essential in patients with primary and secondary adrenal i...
BACKGROUND: Glucocorticoid replacement is essential in patients with primary and secondary adrenal i...
Context: Cortisol has a distinct circadian rhythm regulated by the brain's central pacemaker. Loss o...
Objective: Treatment of classic congenital adrenal hyperplasia (CAH) is necessary to compensate for ...
The aim of glucocorticoid replacement therapy in ACTH-deficient patients is to mimic the normal diur...
Context Hydrocortisone treatment of young patients with 21-hydroxylase deficiency (21OHD) is given t...
Objective: Oral once-daily dual-release hydrocortisone (DR-HC) replacement therapy was developed to ...
Objective: Oral once-daily dual-release hydrocortisone (DR-HC) replacement therapy was developed to ...
Background and objective: Optimisation of hydrocortisone replacement therapy in children is challeng...
International audienceBackgroundAdjustment of daily hydrocortisone dose on clinical criteria lacks s...
International audienceBackgroundAdjustment of daily hydrocortisone dose on clinical criteria lacks s...
International audienceBackgroundAdjustment of daily hydrocortisone dose on clinical criteria lacks s...
International audienceBackgroundAdjustment of daily hydrocortisone dose on clinical criteria lacks s...
There is an increase in mortality and morbidity as well as poor quality of life in patients with con...
<div><p>Background</p><p>Adjustment of daily hydrocortisone dose on clinical criteria lacks sensitiv...
Background: Glucocorticoid replacement is essential in patients with primary and secondary adrenal i...
BACKGROUND: Glucocorticoid replacement is essential in patients with primary and secondary adrenal i...
Context: Cortisol has a distinct circadian rhythm regulated by the brain's central pacemaker. Loss o...
Objective: Treatment of classic congenital adrenal hyperplasia (CAH) is necessary to compensate for ...
The aim of glucocorticoid replacement therapy in ACTH-deficient patients is to mimic the normal diur...
Context Hydrocortisone treatment of young patients with 21-hydroxylase deficiency (21OHD) is given t...